The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlating whole blood AR-V7 and AR-V9 with therapy response to AR-targeted therapies in metastatic castrate-resistant prostate cancer (mCRPC).
 
Edmond Michael Kwan
Consulting or Advisory Role - Ipsen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer; Roche
 
Sarah Q To
No Relationships to Disclose
 
Heidi C Fettke
No Relationships to Disclose
 
Andrew Michael Mant
No Relationships to Disclose
 
Maria M Docanto
No Relationships to Disclose
 
Patricia Bukczynska
No Relationships to Disclose
 
Nicole Ng
No Relationships to Disclose
 
Lisa-Jane K Graham
No Relationships to Disclose
 
Phillip Parente
No Relationships to Disclose
 
Carmel Jo Pezaro
Honoraria - Astellas Pharma; Janssen; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Ferring; Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Pfizer
 
Kate Lynette Mahon
No Relationships to Disclose
 
Lisa Horvath
Research Funding - Astellas Oncology (Inst)
 
Tilman Todenhöfer
Speakers' Bureau - Astellas Oncology; Janssen
Research Funding - Astellas Oncology (Inst)
 
Arun Azad
Honoraria - Amgen; Astellas Pharma; Janssen; Novartis; Pfizer; Tolmar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; Janssen
Research Funding - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma; Sanofi